Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naseem Ahmad Charoo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Cosmetic Dermatology|January 12, 2022
Hyperpigmentation: Looking beyond hydroquinoneNaseem Ahmad Charoo
Clinical Pharmacokinetics|August 7, 2020
Converging Generic Drug Product Development: Bioequivalence Design and Reference Product SelectionNaseem Ahmad Charoo
Drug Development and Industrial Pharmacy|July 5, 2012
Quality risk management in pharmaceutical developmentNaseem Ahmad Charoo, Areeg Anwer Ali
Drug Development and Industrial Pharmacy|February 4, 2014
Pediatric drug development: formulation considerationsAreeg Anwer Ali, Naseem Ahmad Charoo, Daud Baraka Abdallah
Pharmaceutical Biology|February 21, 2014
Comparative binding and disintegrating property of Echinochloa colona starch (difra starch) against maize, sorghum, and cassava starchDaud Baraka Abdallah, Naseem Ahmad Charoo, Abubakr Suliman Elgorashi
Journal of Pharmaceutical Sciences|August 7, 2017
Sample Size for Tablet Compression and Capsule Filling Events During Process ValidationNaseem Ahmad Charoo, Mark Durivage, Ziyaur Rahman, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
Significance of metabolites in bioequivalence: losartan potassium as a case studyNaseem Ahmad Charoo, Rodrigo Cristofoletti, Aamer Roshanali Khatri, et al.
AAPS Pharmscitech|April 17, 2019
Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA ImpuritiesNaseem Ahmad Charoo, Areeg Anwer Ali, Shailesh Kumar Buha, et al.
Pharmaceutical Development and Technology|September 24, 2005
Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino ratsNaseem Ahmad Charoo, Areeg Anwer, Kanchan Kohli, et al.
Colloids and Surfaces. B, Biointerfaces|June 27, 2008
Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oilNaseem Ahmad Charoo, Areeg Anwer Ali Shamsher, Kanchan Kohli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Cosmetic Dermatology|January 12, 2022
Hyperpigmentation: Looking beyond hydroquinoneNaseem Ahmad Charoo
Clinical Pharmacokinetics|August 7, 2020
Converging Generic Drug Product Development: Bioequivalence Design and Reference Product SelectionNaseem Ahmad Charoo
Drug Development and Industrial Pharmacy|July 5, 2012
Quality risk management in pharmaceutical developmentNaseem Ahmad Charoo, Areeg Anwer Ali
Drug Development and Industrial Pharmacy|February 4, 2014
Pediatric drug development: formulation considerationsAreeg Anwer Ali, Naseem Ahmad Charoo, Daud Baraka Abdallah
Pharmaceutical Biology|February 21, 2014
Comparative binding and disintegrating property of Echinochloa colona starch (difra starch) against maize, sorghum, and cassava starchDaud Baraka Abdallah, Naseem Ahmad Charoo, Abubakr Suliman Elgorashi
Journal of Pharmaceutical Sciences|August 7, 2017
Sample Size for Tablet Compression and Capsule Filling Events During Process ValidationNaseem Ahmad Charoo, Mark Durivage, Ziyaur Rahman, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
Significance of metabolites in bioequivalence: losartan potassium as a case studyNaseem Ahmad Charoo, Rodrigo Cristofoletti, Aamer Roshanali Khatri, et al.
AAPS Pharmscitech|April 17, 2019
Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA ImpuritiesNaseem Ahmad Charoo, Areeg Anwer Ali, Shailesh Kumar Buha, et al.
Pharmaceutical Development and Technology|September 24, 2005
Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino ratsNaseem Ahmad Charoo, Areeg Anwer, Kanchan Kohli, et al.
Colloids and Surfaces. B, Biointerfaces|June 27, 2008
Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oilNaseem Ahmad Charoo, Areeg Anwer Ali Shamsher, Kanchan Kohli, et al.
Pageof 1